JPH3

junctophilin 3, the group of Junctophilins

Basic information

Region (hg38): 16:87601835-87698156

Previous symbols: [ "TNRC22" ]

Links

ENSG00000154118NCBI:57338OMIM:605268HGNC:14203Uniprot:Q8WXH2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Huntington disease-like 2 (Definitive), mode of inheritance: AD
  • Huntington disease-like 2 (Strong), mode of inheritance: AD
  • Huntington disease-like 2 (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Huntington disease-like 2ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic11694876; 11761463; 11914418; 11940688; 12805114; 14557581; 18816802; 19735092; 22367996; 22971727

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the JPH3 gene.

  • Inborn_genetic_diseases (161 variants)
  • not_provided (62 variants)
  • JPH3-related_disorder (13 variants)
  • not_specified (7 variants)
  • Huntington_disease-like_2 (4 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the JPH3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000020655.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
28
clinvar
20
clinvar
48
missense
163
clinvar
16
clinvar
1
clinvar
180
nonsense
0
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 0 0 165 44 21
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
JPH3protein_codingprotein_codingENST00000284262 596322
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9990.00145111669011116700.00000448
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3185114911.040.00003604745
Missense in Polyphen118151.960.776541345
Synonymous-5.093242271.430.00001781526
Loss of Function4.29123.40.04270.00000101275

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001010.0000101
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Junctophilins contribute to the formation of junctional membrane complexes (JMCs) which link the plasma membrane with the endoplasmic or sarcoplasmic reticulum in excitable cells. Provides a structural foundation for functional cross-talk between the cell surface and intracellular calcium release channels. JPH3 is brain- specific and appears to have an active role in certain neurons involved in motor coordination and memory.;
Disease
DISEASE: Huntington disease-like 2 (HDL2) [MIM:606438]: Huntington disease (HD) is a neurodegenerative disorder resulting primarily from the loss of medium spiny projection neurons in the striatum, especially in the caudate nucleus, and, to a lesser extent, atrophy of mesencephalic and cortical structures. The typical clinical picture of HD combines familial adult onset chorea and subcortical dementia that usually begin during the fourth decade of life. {ECO:0000269|PubMed:11914418, ECO:0000269|PubMed:14557581}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.264

Intolerance Scores

loftool
rvis_EVS
-1.23
rvis_percentile_EVS
5.54

Haploinsufficiency Scores

pHI
0.134
hipred
Y
hipred_score
0.685
ghis
0.625

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.760

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Jph3
Phenotype
growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;

Gene ontology

Biological process
learning;memory;exploration behavior;locomotion;regulation of synaptic plasticity;regulation of neuronal synaptic plasticity;neuromuscular process controlling balance;release of sequestered calcium ion into cytosol;regulation of ryanodine-sensitive calcium-release channel activity;calcium ion transport into cytosol
Cellular component
endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;junctional sarcoplasmic reticulum membrane;integral component of membrane;junctional membrane complex
Molecular function
molecular_function;calcium-release channel activity